The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery
Abstract
Prostate cancer is the second leading cause of cancer-related deaths in males in the United States. This warrants the development of novel mechanism-based strategies for the prevention and/or treatment of prostate cancer. Several studies have shown that plant-derived alkaloids possess remarkable anticancer effects. Sanguinarine, an alkaloid derived from the bloodroot plant Sanguinaria canadensis, has been shown to possess antimicrobial, anti-inflammatory, and antioxidant properties. Previously, we have shown that sanguinarine possesses strong antiproliferative and proapoptotic properties against human epidermoid carcinoma A431 cells and immortalized human HaCaT keratinocytes. Here, employing androgen-responsive human prostate carcinoma LNCaP cells and androgen-unresponsive human prostate carcinoma DU145 cells, we studied the antiproliferative properties of sanguinarine against prostate cancer. Sanguinarine (0.1–2 μmol/L) treatment of LNCaP and DU145 cells for 24 hours resulted in dose-dependent (1) inhibition of cell growth [as evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay], (2) arrest of cells in G0-G1 phase of the cell cycle (as assessed by DNA cell cycle analysis), and (3) induction of apoptosis (as evaluated by DNA ladder formation and flow cytometry). To define the mechanism of antiproliferative effects of sanguinarine against prostate cancer, we studied the effect of sanguinarine on critical molecular events known to regulate the cell cycle and the apoptotic machinery. Immunoblot analysis showed that sanguinarine treatment of both LNCaP and DU145 cells resulted in significant (1) induction of cyclin kinase inhibitors p21/WAF1 and p27/KIP1; (2) down-regulation of cyclin E, D1, and D2; and (3) down-regulation of cyclin-dependent kinase 2, 4, and 6. A highlight of this study was the fact that sanguinarine induced growth inhibitory and antiproliferative effects in human prostate carcinoma cells irrespective of their androgen status. To our knowledge, this is the first study showing the involvement of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery during cell cycle arrest and apoptosis of prostate cancer cells by sanguinarine. These results suggest that sanguinarine may be developed as an agent for the management of prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Cited by
Alkaloids Isolated from Natural Herbs as the Anticancer Agents
Lu, J.-J., Bao, J.-L., Chen, X.-P., Huang, M., & Wang, Y.-T. (2012) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2012/485042 · Cited by 384
The Biological Activity of Natural Alkaloids against Herbivores, Cancerous Cells and Pathogens
Thawabteh, A., Juma, S., Bader, M., Karaman, D., Scrano, L., Bufo, S., & Karaman, R. (2019) · Toxins · doi:10.3390/toxins11110656 · Cited by 334
Bhadra, K., & Kumar, G. S. (2011) · Medicinal Research Reviews · doi:10.1002/med.20202 · Cited by 305
El-Readi, M. Z., Abdulkarim, M. A., Abdellatif, A. A. H., Elzubeir, M. E., Refaat, B., Althubiti, M., Almaimani, R. A., Mukhtar, M. H., Al-Moraya, I. S., & Eid, S. Y. (2025) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2024.2302557 · Cited by 11
Metadata
- Authors
- Adhami, V. M., Aziz, M. H., Reagan-Shaw, S. R., Nihal, M., Mukhtar, H., & Ahmad, N.
- Venue
- Molecular Cancer Therapeutics
- Published
- 2004-08-01
- Volume
- 3
- Issue
- 8
- Pages
- 933-940
- ISSN
- 1535-7163 (ISSN-L)
- 1538-8514
- OpenAlex
- W2117181237
- Cited by
- 180
- References
- 1
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. https://app.cochat.ai/papers/10.1158/1535-7163.933.3.8
- The paper
- Adhami, V. M., Aziz, M. H., Reagan-Shaw, S. R., Nihal, M., Mukhtar, H., & Ahmad, N. (2004). Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.933.3.8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.